Sam Isaly

Samuel D. Isaly is Managing Partner and Founder of Exome Asset Management. Sam Isaly is an experienced healthcare fund manager and has been active in global healthcare investing and analysis for over 45 years. Over the course of his career, Sam has been a pharmaceutical analyst with Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S.G. Warburg. In 1989, Sam launched OrbiMed Advisors LLC. During his time at OrbiMed, Sam was the portfolio manager of Worldwide Healthcare Trust Plc for 22 years. Sam received an A.B. in Economics from Princeton University and a M.Sc. (Economics) from The London School of Economics.